Article
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: Results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
2021-08-04
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) is used to monitor the quality of diabetes treatment. Its role for prediction of cardiovascular outcomes in the general population remains uncertain. This study aims to assess the role of HbA<sub>1c</sub> in predicting cardiovascular outcomes...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9d19c691-3425-5aa3-9f5c-68367c62376c
- DOI
- 10.21203/rs.3.rs-774608/v1